跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,700 条关于
“Mixed Dyslipidemia”
全部
5,700
临床试验
4,774
药物
57
机构
5
资讯
864
去年
Junshi Biosciences' Ongericimab Approved in China for Hypercholesterolemia and Mixed Dyslipidemia
3个月前
Korean Pharmaceutical Companies Launch New Low-Dose Pitavastatin Combination Therapies for Dyslipidemia Management
去年
FDA Clears Rona Therapeutics' IND for Phase 2 Study of RN0361 in Hypertriglyceridemia
去年
Argo Biopharma and Novartis Expand Partnership with $5.2 Billion Cardiovascular siRNA Deal
去年
Novartis Secures $5.2 Billion Licensing Deal with China's Argo for RNAi Cardiovascular Therapies
8个月前
Adimab Reports 11 New Clinical Programs in 2025, Reaching 89 Total Programs with Six Approved Therapies
上个月
Novel Hypercholesterolemia Drugs Market to Reach USD 42.8 Billion by 2036 as Oral PCSK9 Inhibition and Gene Editing Expand Treatment Options
9个月前
Akeso Achieves Complete NRDL Coverage for Five Innovative Drugs in China, Including First-in-Class Bispecifics
9个月前
RNA Drug Pioneer RiboBio Passes Hong Kong IPO Hearing with $2B+ Partnership Portfolio
去年
NewAmsterdam's Obicetrapib Receives EMA Validation for European Review Following Positive Phase 3 Results
第 1 页,共 87 页
上一页
下一页